Cardiovascular Inhalation for Targeted Drug Delivery in Cardiac Disease – NanoPhoria bioscience

About us
Therapeutic focus
Our Platform
Clinical Programs
- NP-MP1
News
- Press releases

Press releases

23 May 2025

Cardiovascular Inhalation for Targeted Drug Delivery in Cardiac Disease

Connect with us

Learn more about our company and the science behind our revolutionary technology platform

Terms of use

Privacy Policy

Cookies

© NanoPhoria S.r.l. All rights reserved.
VAT number: 12246020965